FDA Schedules July 11, 2025, Meeting on Generic Drug User Fee Amendments Reauthorization
June 03, 2025
June 03, 2025
WASHINGTON, June 3 (TNSmeet) -- The U.S. Department of Health and Human Services Food and Drug Administration is conducting a public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years 2028 to 2032.
This meeting is a crucial step required by the Federal Food, Drug, and Cosmetic Act before the Food and Drug Administration begins negotiations with the regulated industry on GDUFA reauthorization.
The hybrid public meeting will b . . .
This meeting is a crucial step required by the Federal Food, Drug, and Cosmetic Act before the Food and Drug Administration begins negotiations with the regulated industry on GDUFA reauthorization.
The hybrid public meeting will b . . .